# FDA Inspection 1219530 - Yangzhou Liberty Pharmaceuticals Co. Ltd. - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/yangzhou-liberty-pharmaceuticals-co-ltd/baf39705-3d06-4c9a-9d88-bf06cec2f8b6
Source feed: FDA_Inspections

> FDA Inspection 1219530 for Yangzhou Liberty Pharmaceuticals Co. Ltd. on September 15, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219530
- Company Name: Yangzhou Liberty Pharmaceuticals Co. Ltd.
- Inspection Date: 2023-09-15
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1028357 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/yangzhou-liberty-pharmaceuticals-co-ltd/19729e89-d65e-44f4-8740-a97e291b3c8c)
- [FDA Inspection 927841 - 2015-04-24](https://www.keypedia.com/records/fda_inspections/yangzhou-liberty-pharmaceuticals-co-ltd/2f248b24-a09e-40b9-a5a1-6e0b3bd03b3c)

Company: https://www.keypedia.com/companies/yangzhou-liberty-pharmaceuticals-co-ltd/71823610-ebd0-4493-876d-9694002c8995

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c